Shlomi Schwartzblat
Chairman
Revium Rx. (RVRC)Board Member
Revium Rx. (RVRC)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Shlomi Schwartzblat
Shlomi Schwartzblat is recorded as Chairman and Board Member at Revium Rx. (RVRC). Revium Rx. reported in an 8-K filed April 20, 2026 that Shlomi Schwartzblat was appointed Director, effective April 14, 2026. Revium Rx. reported in an 8-K filed April 20, 2026 that Shlomi Schwartzblat was appointed Chairman of the Board, effective April 14, 2026.
“On April 14, 2026, the Board appointed Shlomi Schwartzblat to serve as a Director of the Company, effective immediately, with a term expiring at the annual meeting of stockholders in 2026.”
“In addition, the Board appointed Mr. Schwartzblat as the Chairman of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-04-14–present
-
Current
2026-04-14–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Revium Rx.
Other people whose current roles at this company are on record from its filings.
- Amir Avraham CEO
- Igor Bluvstein CFO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.